Press Release
Jun 21, 2019
Growth Represents the Quality of Research and the Speed to Publication for the IASLC’s Official Journal
DENVER – The International Association for the Study of Lung Cancer (IASLC) announces a significant jump in the 2017 Impact Factor of the Journal of Thoracic Oncology (JTO) to 10.336, up from 6.595 in 2016. The JTO, the official journal of the IASLC, now ranks 11th out of 222 oncology journals and 4th out of 59 respiratory system journals.
The JTO is the primary educational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Emphasizing a multidisciplinary approach, the JTO includes original research, review articles and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists and basic scientists with a special interest in thoracic oncology.
“The JTO is rapidly becoming a leader in the field of thoracic oncology,” said Dr. Alex Adjei, Editor-in-Chief. “Our strong impact factor and quick handling of manuscripts is attractive to many researchers as they consider where to submit.”
The JTO continues to have a quick turn-around time of 10 days to initial decision, and an average of 11 days for revisions, a fast track category, publish on acceptance and promotion of select articles via social media and press releases. Authors can promote their own research by utilizing Elsevier enhancements such as Sharelink and AudioSlides.
To submit a manuscript or to learn more about the JTO, please visit jto.org. Once there, readers can peruse current in-press articles, a collection of lung cancer staging articles or the freely available Editor’s Choice articles. The full contents of the JTO are a free benefit for IASLC members.
An academic journal’s impact factor is a measure of the frequency with which the average article has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the number of times its articles are cited.
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.